DIAGNOSTIC AND THERAPEUTIC STRATEGIES FOR CONDITIONS ASSOCIATED WITH THE FLJ13639 GENE

Provided are methods for determining a prognosis for an individual suspected of having or diagnosed with cancer, where a high CD24/low FLJ13639 ratio indicates an unfavorable prognosis. Also provided are methods for enhancing the activity of chemotherapeutic agents, and isolated, purified FLJ13639 p...

Full description

Saved in:
Bibliographic Details
Main Authors MEGUERDITCHIAN, ARI-NAREG, COIGNET, LIONEL J, NGANGA, ALAIN, JOHNSON, TIMOTHY
Format Patent
LanguageEnglish
French
German
Published 03.09.2008
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
DERIVATIVES THEREOF
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
SPIRITS
SUGARS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Provided are methods for determining a prognosis for an individual suspected of having or diagnosed with cancer, where a high CD24/low FLJ13639 ratio indicates an unfavorable prognosis. Also provided are methods for enhancing the activity of chemotherapeutic agents, and isolated, purified FLJ13639 proteins for use in improving the prognosis of an individual and for enhancing the activity of chemotherapeutic agents.
Bibliography:Application Number: EP20060848867